Vietnam — Strategic Southeast Asia Production Pathway
Gene Bio Medical and BIDIPHAR signed an MOU to explore a diagnostics joint venture, technology transfer and future regional market access.
Trade Commissioner ServiceGlobal Reach
A connected operating model for resilient growth.
GBM connects research, qualified production, regulation and commercialization across markets without treating any single country as the centre of the platform.
01
Capability 01
Global Production & Supply Chain Resilience
GBM maintains control of core intellectual property, brand architecture, quality standards and market channels.
Production capacity is configured through qualified manufacturing partners, strategic collaborations and joint ventures selected for technical capability, regulatory alignment, scalability, operating efficiency and regional access.
Products are manufactured through qualified partner facilities operating under applicable GMP, ISO 13485/MDSAP and regulatory requirements.
02
Capability 02
Omnichannel Cross-Border Commercialization
GBM’s model connects B2B, B2G, B2B2C and direct-to-consumer channels through digital commerce, distribution partnerships, localized market execution and global brand development.
Asia — Digital Commerce & Multi-Channel Market Access
In December 2025, GBM introduced its Asia E-Commerce Operations Centre as a strategic platform for cross-border sales and multi-channel market development.
United States
The United States is a strategic market for future partnership and commercialization pathways.